FOLFIRINOX + RT for Pancreatic Cancer

Clinical trial NCT01591733 · UNKNOWN

Trial details

NCT number: NCT01591733
Sponsor: Massachusetts General Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2012-05-01
Primary completion: 2017-03-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.